What Researchers Did
Researchers compared intratympanic dexamethasone (ITD) and hyperbaric oxygen (HBO) therapies as salvage treatments for 104 patients with refractory high-frequency sudden sensorineural hearing loss (SSNHL).
What They Found
No significant difference was found in overall hearing recovery rates between ITD and HBO groups (p=0.368). However, ITD therapy significantly improved tinnitus (p=0.039) and hearing gains at 8 KHz (p=0.049) compared to HBO therapy.
What This Means for Canadian Patients
For Canadian patients with refractory high-frequency sudden sensorineural hearing loss, intratympanic dexamethasone may offer better relief for tinnitus and improved hearing at higher frequencies compared to hyperbaric oxygen therapy. This suggests ITD could be a more effective salvage treatment option for these specific symptoms after conventional therapies fail.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or patients.
Study Limitations
The study's findings are limited by its specific patient population of refractory high-frequency SSNHL and the relatively small sample size for each treatment group.